TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32167305

Group type: EXPERIMENTAL
Intervention: Sanitation intervention (dual-pit latrines, sani-scoops, child potties)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 34157219

Group type: EXPERIMENTAL
Intervention: Mixed reality application
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anatomy drawing screencasts (Control)
Number of subjects: 0
Study: 33124961

Group type: EXPERIMENTAL
Intervention: Videos with spatial context shifts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Videos without spatial context shifts
Number of subjects: 0
Study: 32096884

Group type: EXPERIMENTAL
Intervention: Self-administered acupressure intervention
Number of subjects: 207
Study: 34519458

Group type: EXPERIMENTAL
Intervention: Vortioxetine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33069871

Group type: EXPERIMENTAL
Intervention: Contrast-rebalanced binocular iPad game play 5 hours/week for 4 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Current treatment only
Number of subjects: 15
Study: 35105186

Group type: EXPERIMENTAL
Intervention: LSD (50 μg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 34014814

Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (EI) using patient navigators and social workers
Number of subjects: 344

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (EI)
Number of subjects: 344
Study: 36245387

Group type: EXPERIMENTAL
Intervention: Boxing training with kicking techniques (BK)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Boxing alone training (BO)
Number of subjects: 29
Study: 34841526

Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg
Number of subjects: 630

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 630
Study: 33295851

Group type: EXPERIMENTAL
Intervention: Curcumin-galactomannan (CGM) 500 mg twice daily for 30 days
Number of subjects: 18
Study: 35732486

Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention including monthly feedback, interactive education, action toolbox, and bimonthly surveys.
Number of subjects: 32923

Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention
Number of subjects: 32923

Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention with QII
Number of subjects: 32923

Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention without QII
Number of subjects: 32923
Study: 35589354

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 300
Study: 33863775

Group type: EXPERIMENTAL
Intervention: Neonatal hyperglycaemia >8 mmol/L
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: Neonatal hyperglycaemia >8 mmol/L for 3 consecutive days
Number of subjects: 533

Group type: COMPARATOR
Intervention: Insulin treatment
Number of subjects: 533
Study: 32081851

Group type: EXPERIMENTAL
Intervention: Older age of menarche
Number of subjects: 8327

Group type: EXPERIMENTAL
Intervention: Later age at menarche
Number of subjects: 8327
Study: 34586459

Group type: EXPERIMENTAL
Intervention: Levilimab (LVL) 324 mg
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study: 32066497

Group type: EXPERIMENTAL
Intervention: 1 g/8 h by continuous infusion (CI)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 2 g/8 h by continuous infusion (CI)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 6 g/day (theoretical highest dose)
Number of subjects: 31
Study: 35699610

Group type: EXPERIMENTAL
Intervention: Enhanced navigation partnered with legal advocates
Number of subjects: 220

Group type: COMPARATOR
Intervention: Standard patient navigation
Number of subjects: 220
Study: 32488654

Group type: EXPERIMENTAL
Intervention: Endobiliary radiofrequency ablation (EB-RFA) with a temperature-controlled catheter (ELRA™) followed by self-expanding metal stent (SEMS) placement
Number of subjects: 48

Group type: COMPARATOR
Intervention: Self-expanding metal stent (SEMS) placement only (non-RFA group)
Number of subjects: 48
Study: 36168108

Group type: EXPERIMENTAL
Intervention: Advance Care Planning (ACP) conversations
Number of subjects: 37
Study: 35226640

Group type: EXPERIMENTAL
Intervention: Safety-net antibiotic prescription (SNAP) offered to patients with AOM.
Number of subjects: 8226
Study: 32046764

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-invasive sham control
Number of subjects: 30
Study: 36122763

Group type: EXPERIMENTAL
Intervention: Weight-loss diets with different macronutrient intakes
Number of subjects: 515
Study: 34987316

Group type: EXPERIMENTAL
Intervention: Directional Coronary Atherectomy (DCA) followed by drug-coated balloon (DCB) angioplasty
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Directional Coronary Atherectomy (DCA)
Number of subjects: 31
Study: 32804580

Group type: EXPERIMENTAL
Intervention: Neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP) combined detection
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Moderate group of COVID-19 patients
Number of subjects: 191

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: NLR, CRP, and lymphocyte percentage
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: NLR, CRP, WBC, and lymphocyte percentage
Number of subjects: 191
Study: 33729249

Group type: EXPERIMENTAL
Intervention: Randomised 'spot-scan' mode of imaging in STEM
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uniformly illuminated TEM mode of imaging
Number of subjects: 0
Study: 33380614

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline injection (Control)
Number of subjects: 24
Study: 32592596

Group type: EXPERIMENTAL
Intervention: COC + VPR (2 mg/d vilaprisan)
Number of subjects: 71

Group type: COMPARATOR
Intervention: COC + Placebo
Number of subjects: 71
Study: 33039321

Group type: EXPERIMENTAL
Intervention: Fertility education chatbot
Number of subjects: 927

Group type: COMPARATOR
Intervention: Document about fertility and preconception health (Control group 1)
Number of subjects: 927

Group type: COMPARATOR
Intervention: Document about an irrelevant topic (Control group 2)
Number of subjects: 927
Study: 32970283

Group type: EXPERIMENTAL
Intervention: Genetically longer self-reported sleep duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Longer self-reported sleep duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Accelerometer-derived sleep duration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-reported sleep duration
Number of subjects: 0
Study: 36442186

Group type: EXPERIMENTAL
Intervention: Hybrid warm-up intervention (HWU)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dynamic warm-up intervention (DWU)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Stretching warm-up intervention (SWU)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No warm-up intervention (NWU)
Number of subjects: 120
Study: 35995936

Group type: COMPARATOR
Intervention: Control group (reminder to attend regular screening)
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: Opt-in group (offer to order a self-sampling kit for HPV testing)
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: Send-to-all group (self-sampling kit unsolicited for HPV testing)
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: Self-sampling (both opt-in and send-to-all)
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Clinician-collected samples
Number of subjects: 6000
Study: 33840798

Group type: EXPERIMENTAL
Intervention: Wheat oral immunotherapy (WOIT)
Number of subjects: 0
Study: 35377238

Group type: EXPERIMENTAL
Intervention: Patient-directed music (PDM) listening protocol
Number of subjects: 126
Study: 34350266

Group type: EXPERIMENTAL
Intervention: Total left‐sided surgical approach (TLSA)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Traditional bilateral surgical approach (TBSA)
Number of subjects: 114
Study: 36430967

Group type: EXPERIMENTAL
Intervention: Melatonin 1 mg/day for 1 year
Number of subjects: 23

Group type: COMPARATOR
Intervention: Hypertensive controls
Number of subjects: 23
Study: 34383515

Group type: EXPERIMENTAL
Intervention: Moms' Empowerment Program
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Higher IPV exposure
Number of subjects: 118

Group type: COMPARATOR
Intervention: Higher depression symptoms
Number of subjects: 118

Group type: COMPARATOR
Intervention: Shelter use
Number of subjects: 118
Study: 32886189

Group type: EXPERIMENTAL
Intervention: 12-month exercise program (weekly supervised step aerobics, circuit exercises, and home training)
Number of subjects: 573

Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: 12-month exercise program
Number of subjects: 573

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 573
Study: 33030312

Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate (DMPA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reduction in DMPA use among HIV-positive women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Switching away from DMPA to no contraceptive method
Number of subjects: 0
Study: 36201131

Group type: EXPERIMENTAL
Intervention: Once-off screening at age 50 years
Number of subjects: 10000000

Group type: COMPARATOR
Intervention: All screening strategies
Number of subjects: 10000000

Group type: EXPERIMENTAL
Intervention: Polygenic risk-stratified screening strategies
Number of subjects: 10000000

Group type: COMPARATOR
Intervention: No screening
Number of subjects: 10000000
Study: 32938990

Group type: EXPERIMENTAL
Intervention: Inhaled prostaglandin-E2 (PGE2) 100 μg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Inhaled bradykinin (BK) 200 μg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Diluent (Control)
Number of subjects: 17
Study: 36074603

Group type: EXPERIMENTAL
Intervention: Mentoring group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) group
Number of subjects: 0
Study: 32513182

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg∙kg‐1)
Number of subjects: 20
Study: 34896350

Group type: EXPERIMENTAL
Intervention: CSFL risk prediction nomogram
Number of subjects: 1286
Study: 32174345

Group type: EXPERIMENTAL
Intervention: 20% body mass (BM) bilateral load
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 20% BM unilateral load
Number of subjects: 24

Group type: COMPARATOR
Intervention: No load
Number of subjects: 24
Study: 36563900

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) ferric carboxymaltose
Number of subjects: 64

Group type: COMPARATOR
Intervention: Oral ferrous fumarate
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 64
Study: 33187676

Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) model based on radiomics features
Number of subjects: 136

Group type: COMPARATOR
Intervention: Radiologists
Number of subjects: 136
Study: 33367545

Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO)
Number of subjects: 469

Group type: COMPARATOR
Intervention: Control group (intensive chemotherapy without GO)
Number of subjects: 469
Study: 35501468

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Ultrasound-Guided Caudal Epidural Blocks (CEB)
Number of subjects: 95
Study: 34193177

Group type: EXPERIMENTAL
Intervention: Sequential finger task in REs
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sequential reaching task in VEs
Number of subjects: 27
Study: 35700246

Group type: EXPERIMENTAL
Intervention: Home-based exercise training after inpatient rehabilitation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Inpatient rehabilitation exercise training
Number of subjects: 100
Study: 34257678

Group type: EXPERIMENTAL
Intervention: Ayurveda drug regimen arm II
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ayurveda drug regimen arm I
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intervention arms
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Experimental arms
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 120
Study: 34759244

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 364

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (subgroup for tumors ≤5 cm)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Open surgery (subgroup for tumors ≤5 cm)
Number of subjects: 364
Study: 35688677

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (5 mg/kg) and 0.25% bupivacaine (1 mg/kg)
Number of subjects: 75

Group type: COMPARATOR
Intervention: 0.25% bupivacaine (1 mg/kg)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Saline solution (NaCl)
Number of subjects: 75
Study: 33244709

Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC) combined with maternal singing during music therapy (MT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Skin-to-skin contact (SSC) alone
Number of subjects: 35
Study: 37315900

Group type: EXPERIMENTAL
Intervention: Daily probiotic
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intermittent fasting
Number of subjects: 24
Study: 34297997

Group type: COMPARATOR
Intervention: PICC
Number of subjects: 1061

Group type: EXPERIMENTAL
Intervention: Hickman
Number of subjects: 1061

Group type: EXPERIMENTAL
Intervention: PORT
Number of subjects: 1061
Study: 35192201

Group type: EXPERIMENTAL
Intervention: Cycling
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Rowing
Number of subjects: 101
Study: 33586578

Group type: EXPERIMENTAL
Intervention: Loud personal listening device (PLD) usage
Number of subjects: 4807

Group type: EXPERIMENTAL
Intervention: High PLD usage (equivalent to or above 85 dBA, LEX 40)
Number of subjects: 4807

Group type: EXPERIMENTAL
Intervention: Five years or more of loud PLD usage
Number of subjects: 4807

Group type: EXPERIMENTAL
Intervention: Loud or high PLD usage
Number of subjects: 4807
Study: 33225646

Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery (ERAS) protocol
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 150
Study: 35584639

Group type: EXPERIMENTAL
Intervention: Inference-based cognitive-behavioral therapy (I-CBT)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Appraisal-based cognitive behavioral therapy (A-CBT)
Number of subjects: 111
Study: 33968872

Group type: EXPERIMENTAL
Intervention: Multi-component training program (12 hours total duration)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Multi-component training program (minimum of 8 hours)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Baseline assessment
Number of subjects: 25
Study: 35661128

Group type: EXPERIMENTAL
Intervention: Active stimulation
Number of subjects: 55
Study: 32313142

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) plus docetaxel
Number of subjects: 790

Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT) alone
Number of subjects: 790
Study: 35430239

Group type: EXPERIMENTAL
Intervention: Customized 3D printed pillboxes
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Customized off‐the‐shelf pillboxes
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard‐of‐care pillbox
Number of subjects: 15
Study: 34113093

Group type: EXPERIMENTAL
Intervention: Inhaled nemiralisib (1 mg)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 32323191

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (twice-daily dosing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (once-daily dosing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (both dosing periods)
Number of subjects: 0
Study: 32066302

Group type: EXPERIMENTAL
Intervention: Pine-tar bath oil
Number of subjects: 0
Study: 32450914

Group type: EXPERIMENTAL
Intervention: Wolbachia-infected Aedes aegypti deployments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated clusters
Number of subjects: 0
Study: 35319737

Group type: EXPERIMENTAL
Intervention: Question prompt list brochure
Number of subjects: 446

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Surgeon reluctance to operate
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Longer conversations
Number of subjects: 446
Study: 35590791

Group type: EXPERIMENTAL
Intervention: Ethanol consumption (beer) with a mixed meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-alcohol scenario
Number of subjects: 12
Study: 33624071

Group type: EXPERIMENTAL
Intervention: Combined aerobic training (AT)/resistance training (RT)/inspiratory muscle training (IMT) (ARIS)
Number of subjects: 88
Study: 32376984

Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT) - 40 minutes of cycling at 50-75% heart rate reserve, 2 times a week for 8 weeks
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) - 6 resistance exercises, 4 × 12 repetitions at 60% maximum strength, 2 times a week for 8 weeks
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combined Training (CT) - 2 × 12 repetitions of RT + 20 minutes of AT, 2 times a week for 8 weeks
Number of subjects: 42
Study: 35265985

Group type: EXPERIMENTAL
Intervention: Contezolid 800 mg q12h
Number of subjects: 626

Group type: COMPARATOR
Intervention: Linezolid 600 mg q12h
Number of subjects: 626
Study: 35895867

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 2306

Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 2306

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 2306
Study: 34880300

Group type: EXPERIMENTAL
Intervention: Intranasal Oxytocin (OT) 24 IU
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33152067

Group type: EXPERIMENTAL
Intervention: Brief alcohol intervention (BAI) delivered by computer-generated individualized feedback letters at baseline, 3 and 6 months
Number of subjects: 1646

Group type: COMPARATOR
Intervention: Assessment only (Control)
Number of subjects: 1646
Study: 32171297

Group type: EXPERIMENTAL
Intervention: Whole case format
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Serial cue case format
Number of subjects: 142

Group type: COMPARATOR
Intervention: Whole case and serial cue formats
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: High prior knowledge students
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Low prior knowledge students
Number of subjects: 142
Study: 35870491

Group type: EXPERIMENTAL
Intervention: DMEK
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: UT‐DSAEK
Number of subjects: 50

Group type: COMPARATOR
Intervention: DMEK vs UT‐DSAEK
Number of subjects: 50
Study: 33602441

Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 14628

Group type: COMPARATOR
Intervention: Dual-antiplatelet therapy (DAPT)
Number of subjects: 14628
Study: 35092544

Group type: EXPERIMENTAL
Intervention: Yoga with active tDCS (2 mA; 20 min; anode-F3, cathode-F4)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Yoga with sham tDCS
Number of subjects: 22
Study: 33600918

Group type: EXPERIMENTAL
Intervention: Ashwagandha root extract (300 mg, twice daily for 8 weeks)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ashwagandha root extract
Number of subjects: 50
Study: 34789346

Group type: EXPERIMENTAL
Intervention: Diet with highest STPP inclusion level and lowest Ca:P
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All experimental diets
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Diet with intended total Ca:P of about 1.0, 1.5 or 2.0
Number of subjects: 24
Study: 33801337

Group type: EXPERIMENTAL
Intervention: Co‐Cr ceramic prosthesis (conventional method)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Co‐Cr ceramic prostheses (CAD/CAM technique)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Zirconia‐based prostheses (CAD/CAM technique)
Number of subjects: 95
Study: 34176657

Group type: EXPERIMENTAL
Intervention: Anatomy-based retraining program (MusAARP)
Number of subjects: 4
Study: 32125300

Group type: EXPERIMENTAL
Intervention: Individual milled transdental implants made of zirconium dioxide; patients with apical periodontitis of incisors, canines or premolars.
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Individual milled transdental implants made of zirconium dioxide; patients with similar diagnosis and concomitant periodontitis of moderate severity.
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Individual milled transdental implants made of zirconium dioxide; patients with periapical destructive process of molars without periodontitis.
Number of subjects: 96

Group type: COMPARATOR
Intervention: Resection of the root apex without implantation; control group.
Number of subjects: 96
Study: 33608007

Group type: EXPERIMENTAL
Intervention: Targeted lung denervation (TLD) therapy
Number of subjects: 34
Study: 36082054

Group type: EXPERIMENTAL
Intervention: 640-slice CT scan
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional CT scan
Number of subjects: 120
Study: 35056313

Group type: EXPERIMENTAL
Intervention: Cognitive assessment (MMSE/MoCA)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Stabilometric platform measurements
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Fatigue syndrome assessment using the Fatigue Severity Scale (FSS)
Number of subjects: 76
Study: 34862002

Group type: EXPERIMENTAL
Intervention: Transfusion with one unit of RBCs (haemoglobin group)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Transfusion only if the ScvO2 was <70% (individualised group)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 164
Study: 33298133

Group type: EXPERIMENTAL
Intervention: Access to UMIMS educational tool
Number of subjects: 120

Group type: COMPARATOR
Intervention: Access to control website
Number of subjects: 120